Quidel Corp. Hosts Upcoming Webinar to Help Health Professionals Distinguish Lyme Disease, Flu & COVID-19 During Frightening ...
November 19 2020 - 10:00AM
Business Wire
With the common symptoms of flu, COVID-19 and Lyme disease all
converging to form a frightening respiratory season, health care
professionals nationwide will converge themselves to join an
important webinar on Dec. 3 focused on how to correctly diagnose
and treat these look-alike conditions. The webinar is being
sponsored by Quidel, the California-based diagnostic health care
manufacturer known for successfully developing rapid diagnostic
health solutions.
As reported by the Centers for Disease Control and Prevention,
the trio of Lyme disease, flu and COVID-19 share the common
symptoms of fever/chills, fatigue, muscle aches and headaches. That
makes it both challenging and critical for health care
professionals to properly distinguish one from the other so that
they can correctly treat their patients for the corresponding
ailment.
“In particular, physicians need to have their radar up for Lyme
disease, which is known as ‘The Great Imitator’ because its
symptoms often mimic those of flu and, most recently, COVID-19
infections,” said Roxanne Carfora, D.O., who will be conducting the
webinar. “Early diagnosis of Lyme disease is critical because if
not caught early or if misdiagnosed, Lyme disease can have
long-term debilitating consequences. With Lyme disease afflicting
as many as 400,000 Americans each year, we view this as an epidemic
within the pandemic.”
A recovering Lyme disease patient herself, Dr. Carfora is board
certified in anti-aging and functional medicine and has been
practicing family medicine on Long Island for more than 25 years.
She is the founder of New York-based Ageless MD, which combines
family medicine, anti-aging medicine and aesthetics in one
patient-friendly environment. Dr. Carfora is a graduate of New York
College of Osteopathic Medicine, host of the radio program “Getting
You Healthy, Naturally” and co-author of “Ageless Adventures,”
which provides tips on how to live a more active, healthy
lifestyle.
Lyme disease is a bacterial infection that is spread when people
are bitten by an infected deer tick. It can strike anyone at any
age and can lead to a number of serious, life-threatening problems
if not caught early. Leading the way in Lyme disease testing is
Quidel’s innovative Sofia® 2 Lyme FIA test. This test provides a
patient as well as his or her physician with indicative results
within minutes as opposed to days, which has historically been the
norm. Performed in the privacy of a doctor’s office or local
clinic, it is also the only test that can get results from a simple
finger prick of blood. With appropriate antibiotic treatment, most
people with Lyme disease recover completely; but the key is
catching it early, and that means not hesitating to get tested.
Among those expected to attend the free Dec. 3 webinar are
physicians; allied health professionals; health researchers; and
representatives of physician offices, laboratories, urgent care
centers and others interested in the subject. The webinar, titled,
“Doctor, I’m exhausted and have a fever. Do I have COVID? Could it
be the flu or even Lyme disease?” will take place from noon-1 p.m.
(EDT). To register, visit quidel.com/webinars.
About Quidel Corporation
Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of
diagnostic solutions at the point of care, delivering a continuum
of rapid testing technologies that further improve the quality of
health care throughout the globe. An innovator for over 40 years in
the medical device industry, Quidel pioneered the first FDA-cleared
point-of-care test for influenza in 1999 and was the first to
market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted
brand names, Sofia®, Solana®, Lyra®, Triage® and QuickVue®,
Quidel’s comprehensive product portfolio includes tests for a wide
range of infectious diseases, cardiac and autoimmune biomarkers, as
well as a host of products to detect COVID-19. With products made
in America, Quidel’s mission is to provide patients with immediate
and frequent access to highly accurate, affordable testing for the
good of our families, our communities and the world. For more
information about Quidel, visit quidel.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201119005505/en/
Jim Yeager 424.644.0225 (office) 818.264.6812 (mobile)
jim@breakwhitelight.com
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From May 2024 to Jun 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Jun 2023 to Jun 2024